About Eagles Pharma · South Sudan
About Eagles Pharma · South Sudan
Founded on the conviction that every patient in South Sudan deserves access to authentic, appropriately regulated, and affordable medicines.
The Republic of South Sudan possesses a resilient population and an expanding network of dedicated healthcare facilities. However, the nation's pharmaceutical supply chain faces persistent structural hurdles: severe geographical dispersion, transport bottlenecks from international entry ports, unpredictable product lead times, and the acute risk of counterfeit medicines.
Eagles Pharma was conceived as a targeted institutional solution. Rather than functioning as an opportunistic trader or retail pharmacy, Eagles Pharma is designed from inception as a disciplined, quality-first pharmaceutical distribution organization.
Our guiding mandate is to construct direct bridges between reputable international pharmaceutical manufacturers—such as our ongoing exploratory dialogue with Addii Biotech Pvt. Ltd. (India)—and the hospitals, clinics, pharmacies, and humanitarian agencies operating on the frontlines across South Sudan.
Accelerating Access from Molecule to Market
Republic of South Sudan
A clear ethical and operational compass guiding every operational framework we establish.
To sustainably improve access to quality, affordable, and appropriately regulated essential medicines across the Republic of South Sudan by establishing transparent relationships with verified pharmaceutical manufacturers, healthcare institutions, hospitals, clinics, community pharmacies, and humanitarian organizations.
To contribute decisively to strengthening South Sudan's national healthcare supply ecosystem through responsible pharmaceutical distribution, uncompromised Good Distribution Practices (GDP), cold-chain excellence, and enduring partnerships that elevate patient safety.
Zero tolerance for unverified or grey-market medicines. Strict WHO-GMP and Certificate of Analysis compliance for every incoming batch.
Full fidelity to the laws of the Republic of South Sudan, DFCA regulations, and rigorous pharmacovigilance documentation.
Engineering efficient distribution logistics to compress markups and make essential life-saving therapies affordable for all communities.
Operating as an open, accountable partner for global pharmaceutical manufacturers and humanitarian agencies working across East Africa.
Structured phased goals guiding Eagles Pharma from corporate establishment to nationwide healthcare supply leadership.
In pharmaceutical distribution, technical governance is paramount. Eagles Pharma is being assembled under the stewardship of pharmaceutical management professionals, regulatory affairs experts, and experienced supply chain logisticians with firsthand familiarity with the East African operating environment.
Our governance framework separates commercial decisions from quality assurance: our Quality Assurance and Regulatory Compliance officers hold absolute veto authority over batch intake, storage conditions, and distribution release.
Corporate Pre-Launch Stage
Formal executive officer profiles, technical directors, and advisory board members will be publicly introduced upon the conclusion of incorporation and the granting of distributor licenses by the Ministry of Health and DFCA.
For executive inquiries or advisory communications with our corporate founding desk, please submit through our corporate contact portal.
Eagles Pharma adheres to absolute transparency. We do not claim existing distribution licenses or commercial accreditations that have not yet been granted. We are currently actively fulfilling all prerequisite statutory steps to establish an exemplary, fully compliant pharmaceutical distribution company in the Republic of South Sudan.
Legal disclosure regarding company status in South Sudan
All commercial distribution arrangements, including exploratory discussions with Addii Biotech Pvt. Ltd. (India), are non-binding and subject to final formal agreements and regulatory approvals by the Drug and Food Control Authority (DFCA).
Engage with Eagles Pharma pre-launch corporate team
Thank you for your interest. Reference Code: EP-PRQ-2026